Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 2 |
2010 | 2 |
2012 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.
Haematologica. 2009 Apr;94(4):542-9. doi: 10.3324/haematol.2008.000927. Epub 2009 Mar 10.
Haematologica. 2009.
PMID: 19278968
Free PMC article.
BACKGROUND: After successful treatment of malignant diseases, therapy-related myelodysplastic syndrome and acute myeloid leukemia have emerged as significant problems. DESIGN AND METHODS: The aim of this study was to investigate outcome and risk factors in patients with th …
BACKGROUND: After successful treatment of malignant diseases, therapy-related myelodysplastic syndrome and acute myeloid leukemia hav …
Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients.
Ringdén O, Labopin M, Beelen DW, Volin L, Ehninger G, Finke J, Greinix HT, Kyrcz-Krzemien S, Bunjes D, Brinch L, Niederwieser D, Arnold R, Mohty M, Rocha V; Acute Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O, et al.
J Intern Med. 2012 Nov;272(5):472-83. doi: 10.1111/j.1365-2796.2012.02547.x. Epub 2012 May 21.
J Intern Med. 2012.
PMID: 22519980
Free article.
The incidence of acute graft-versus-host disease (GVHD) was similar, but there was more chronic GVHD in the blood stem cell group [hazard ratio (HR) = 1.29, P = 0.02]. ...In patients with advanced leukaemia, NRM was lower (HR = 0.61, P = 0.02) and LFS was prolonged …
The incidence of acute graft-versus-host disease (GVHD) was similar, but there was more chronic GVHD in the blood stem cell group [ha …
Item in Clipboard
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT.
Chalandon Y, Passweg JR, Schmid C, Olavarria E, Dazzi F, Simula MP, Ljungman P, Schattenberg A, de Witte T, Lenhoff S, Jacobs P, Volin L, Iacobelli S, Finke J, Niederwieser D, Guglielmi C; Chronic Leukemia Working Party of European Group for Blood and Marrow Transplantation.
Chalandon Y, et al.
Bone Marrow Transplant. 2010 Mar;45(3):558-64. doi: 10.1038/bmt.2009.177. Epub 2009 Jul 27.
Bone Marrow Transplant. 2010.
PMID: 19633691
A total of 122 patients (38%) developed some form of GVHD. We analyzed GVHD by clinical presentation (acute or chronic GVHD) and onset time after the first DLI (early (< or =45 days) or late (>45 days)). ...Some form of GVHD occurred at a median of 104 days, acute GV …
A total of 122 patients (38%) developed some form of GVHD. We analyzed GVHD by clinical presentation (acute or chronic GVHD) and onse …
Item in Clipboard
Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients.
Mutis T, Brand R, Gallardo D, van Biezen A, Niederwieser D, Goulmy E; Chronic Leukemia Working Party of European Group for Blood and Marrow Transplantation (EBMT); Spanish Group of hematopoietic Transplant (GETH).
Mutis T, et al.
Leukemia. 2010 Jul;24(7):1388-92. doi: 10.1038/leu.2010.115. Epub 2010 May 27.
Leukemia. 2010.
PMID: 20508613
No abstract available.
Item in Clipboard
Cite
Cite